PORCILIS PCV VACCINE

Ország: Ausztrália

Nyelv: angol

Forrás: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktív összetevők:

PORCINE CIRCOVIRUS TYPE 2 ORF2 SUBUNIT ANTIGEN

Beszerezhető a:

INTERVET AUSTRALIA PTY LIMITED

INN (nemzetközi neve):

porcine circovirus type 2

Gyógyszerészeti forma:

MISC. VACCINES OR ANTI SERA

Összetétel:

PORCINE CIRCOVIRUS TYPE 2 ORF2 SUBUNIT ANTIGEN VACCINE-VIRAL Active 2.0 mg/2mL

db csomag:

1 x 100 mL (50 doses); 1 x 20 mL (10 doses); 1 x 200 mL (100 doses); 1 x 50 mL (25 doses); 1 x 500 mL (250 doses); 10 x 20 mL (100 doses); 5 x 20 mL (50 doses)

Osztály:

VM - Veterinary Medicine

Gyártó:

INTERVET AUSTRALIA

Terápiás terület:

IMMUNOTHERAPY

Termék összefoglaló:

Poison schedule: 0; Withholding period: Zero (0) days. EXPORT SLAUGHTER INTER VAL (ESI): Zero (0) days. Before using this product, confirm the current ESI f rom Intervet Australia Pty Limited on 18 00 033 461 or the APVMA website (www.apv ma.gov.au/residues).; Host/pest details: PIG: [PREVENTING WEIGHT LOSS, REDUCED MORTALITY, REDUCTION OF LYMPHOID DEPLETION ]; Poison schedule: 0; Withholding period: WHP: Zero (0) days. ESI: ESI not requi red.; Host/pest details: PIG: [PREVENTING WEIGHT LOSS, REDUCED MORTALITY, REDUCTION OF LYMPHOID DEPLETION ]; Poison schedule: 0; Withholding period: ; Host/pest details: PIG: [PREVENTING WEIGHT LOSS, REDUCED MORTALITY, REDUCTION OF LYMPHOID DEPLETION ]; For active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce mortality and weight loss associated with Porcine circovirus type 2 related infection (PCVD) occurring during the fattening period.

Engedélyezési státusz:

Registered

Engedély dátuma:

2023-07-01

Betegtájékoztató

PORCILIS PCV VACCINE
64025 / 124319
Product Name:
APVMA Approval No:
Label Name:
PORCILIS PCV VACCINE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Porcine Circovirus Type 2 ORF2 subunit antigen: ≥ 4.5 log2 antibody
titre per dose of 2 mL.
Also contains:
346 mg light liquid paraffin (adjuvant)
25 mg dl-α-tocopheryl acetate (adjuvant)
Claims:
For active immunisation of pigs to reduce the virus load in blood and
lymphoid tissues
and to reduce mortality and weight loss associated with Porcine
circovirus type 2 related
infection (PCVD) occurring during the fattening period.
Onset of immunity: 2 weeks
Duration of immunity: 22 weeks
A single dose breaks through up to medium levels of maternally derived
antibodies in
piglets.
A double dose breaks through medium to high levels of maternally
derived antibodies.
Net Contents:
1 x 20 mL (10 doses)
5 x 20 mL (50 doses)
10 x 20 mL (100 doses)
1 x 50 mL (25 doses)
1 x 100 mL (50 doses)
1 x 200 mL (100 doses)
1 x 500 mL (250 doses)
Directions for Use:
Restraints:
DO NOT mix with any other vaccine or immunological product.
Contraindications: RLP APPROVED
Precautions:
Side Effects:
In laboratory studies and field trials:
A transient rise in body temperature may occur until 2 days after
vaccination. Some piglets
may be depressed and show a reduced feed intake for up to 5 days. A
transient local
reaction at the injection site may be observed in the form of a hard
and sometimes warm
swelling (up to a diameter of 7cm) diminishing over a period of
approximately 14-21 days. A
hypersensitivity-like reaction may occur; the animals will recover in
several minutes without
further treatment.
In post marketing experience:
In very rare cases anaphylactic-type reactions can occur, which may be
life-threatening. In
the event of such reactions, treatment may be needed.
Dosage and
Administration:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
SHAKE WELL BEFORE USE.
USE THE ENTIRE CONTENTS WITHIN 8 HOURS OF OPENING.
The vaccine is a liquid and ready-to-use product. Be